The CAPTURE (Carotid Artery Implant for Trapping Upstream Emboli for Preventing Stroke in Atrial Fibrillation Patients) clinical trial is a first-in-human, four center, non-randomized, feasibility study of the CCA filter. An independent Data Safety Monitoring Board oversaw the safety of the trial, and an independent Clinical Events Committee adjudicated endpoint events.
What I appreciate the most about genae is the consistent level of quality they produce. Our medical device study team is knowledgeable, capable and experienced; flexible with our changing needs, and very responsive to our concerns.
— Sara Vidmar, Vice President Clinical & Regulatory Affairs, Mitralign Inc., USA
Want to hear more about our services or how we can support your project? Feel free to contact us with any questions you may have.Contact us